Caprolactam Chemicals Ltd

Caprolactam Chemicals Ltd., a micro-cap commodity chemicals manufacturer with a market capitalisation of ₹22.00 crores, reported a remarkable turnaround in Q4 FY26 (January-March 2026), posting net profit of ₹0.84 crores compared to a loss of ₹0.45 crores in the same quarter last year. The stock has responded positively to the operational recovery, gaining 18.60% over the past year, though it remains 39.46% below its 52-week high of ₹81.00. At the current market price of ₹49.04, the company trades at a concerning valuation of 2,254 times trailing twelve-month earnings, raising serious questions about sustainability despite improved fundamentals.

Caprolactam Chemicals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026, driven primarily by deteriorating technical indicators and stagnant financial performance. Despite a modest one-year stock return outperforming the broader market, the company’s weak fundamentals and bearish technical trends have raised concerns among analysts and investors alike.

Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a significant shift in its valuation parameters, raising questions about its price attractiveness amid a volatile market backdrop. The company’s price-to-earnings (P/E) ratio has surged to an extraordinary 2,688.7, while its price-to-book value (P/BV) stands at 5.05, marking a transition from fair to expensive valuation territory. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide investors with a comprehensive perspective.

Caprolactam Chemicals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating despite its sky-high price-to-earnings (P/E) ratio. This transition reflects a complex interplay of market sentiment, financial metrics, and sector comparisons, raising important considerations for investors navigating the commodity chemicals space.

Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. Despite a challenging market environment reflected in its recent share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential re-rating opportunity relative to its historical and peer benchmarks.

Caprolactam Chemicals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade despite a significant decline in its share price. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons within the commodity chemicals sector.

Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Caprolactam Chemicals Ltd has surged to a fresh 52-week high of Rs.81, marking a significant milestone in its stock performance. This new peak reflects strong momentum as the stock continues its upward trajectory, outperforming its sector and broader market indices.

Caprolactam Chemicals Ltd has surged to a fresh 52-week high of Rs.77.7, marking a significant milestone in its stock performance. This new peak reflects strong momentum in the commodity chemicals sector, with the stock outperforming its peers and broader market indices over recent sessions.

Caprolactam Chemicals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.76.16, marking a notable surge in its stock price and reflecting strong momentum within the commodity chemicals sector.

Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Caprolactam Chemicals Ltd has surged to a fresh 52-week high of Rs.71.23, marking a significant milestone in its stock performance. This new peak reflects a robust rally driven by sustained buying momentum and strong technical positioning within the commodity chemicals sector.

Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the most recent and relevant data to assess the company’s outlook.

Caprolactam Chem, a microcap player in the Commodity Chemicals sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This development comes amid a backdrop of mixed financial performance and sector dynamics, prompting investors to reassess the stock’s positioning.

Caprolactam Chemicals Ltd experienced a pronounced decline on 5 Dec 2025, marked by a complete absence of buyers and a sharp fall of 5.0% in its share price. This downward movement follows two consecutive days of losses, signalling heightened selling pressure and distress among investors in the commodity chemicals sector.

Caprolactam Chemicals Ltd has encountered a rare market phenomenon today, with the stock registering a lower circuit and an exclusive queue of sell orders, signalling extreme selling pressure and distress selling. Despite a strong run of consecutive gains over the past eight days, the stock’s current trading session reveals a stark absence of buyers, raising concerns about market sentiment and potential volatility ahead.

Caprolactam Chemicals Ltd witnessed a sharp decline today as the stock hit its lower circuit, marked by an overwhelming presence of sell orders and an absence of buyers. This extreme selling pressure signals distress among investors, with the stock closing down 5.00% against a marginal 0.30% fall in the Sensex, underscoring the severity of the sell-off in the commodity chemicals sector.